AlphaStocks

VAL vs ZTS

As of Sep 20, 2026, Valaris (VAL) scores 4.6/10 and Zoetis (ZTS) 4.3/10 on AlphaStocks' five-model composite, so VAL scores higher.

VAL

Valaris Ltd

4.6

Weak

$83.77

ZTS

Zoetis Inc.

4.3

Weak

$71.46

VAL vs ZTS: Which is the Better Investment?

Valaris Ltd (VAL) scores 4.6/10 while Zoetis Inc. (ZTS) scores 4.3/10 on AlphaStocks' composite model. Valaris Ltd has the higher composite rating of Weak. On a P/E basis, Valaris Ltd trades at 6.0x, making it the more attractively priced of the two.

This comparison is algorithmically generated and is not financial advice.

MetricVALZTS
Scores & Fundamentals
Composite Score4.6/104.3/10
RatingWeakWeak
Price$83.77$71.46
P/E Ratio6.011.9
ROE35.0%60.7%
Market Cap$6B$30B
Fair Value
Dividend Yield2.7%
Sector Rank#37 of 80#131 of 168
Model Verdicts
PiotroskiStrongStrong
BuffettAttractiveStrong
GrahamNeutralNeutral
LynchNeutralAttractive
GreenblattAttractiveStrong
View full VALanalysis →View full ZTSanalysis →

Related comparisons

Compare any two stocks →

VAL vs ZTS: Which Stock Scores Higher?

Valaris Ltd (VAL) is in the Energy sector; Zoetis Inc. (ZTS) is in Health Care. VAL currently leads with a composite score of 4.6/10 (Weak) compared to ZTS's 4.3/10 (Weak).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer